CRF Health’s TrialMax Touch® Solution Selected for Landmark Global Oncology Study

Published on: 

Applied Clinical Trials

CRF Health announced that its TrialMax Touch® solution has been selected for a landmark global oncology trial. The trial will involve more than 1,000 patients across 200 sites in 20 countries and provide a version of TrialMax solution to all involved. Not only does this solution increase insight to Patient Reported Outcomes, but it also streamlines data collection by capturing the data. 

Read the full release here.